CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-12 | Payne Fletcher Chief Financial Officer | Grant or award | +1,180 | $6.51 | $8K | 3,744 |
| 2019-02-11 | Payne Fletcher Chief Financial Officer | Grant or award | +1,002 | $7.04 | $7K | 3,731 |
| 2019-02-04 | Payne Fletcher Chief Financial Officer | Exercise or conversion | +1,503 | $4.63 | $7K | 3,230 |
| 2019-02-04 | Payne Fletcher Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −1,503 | 73,497 | ||
| 2019-01-24 | Payne Fletcher Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2018-07-30 | Payne Fletcher Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-03-26 | Payne Fletcher Chief Financial Officer | Exercise or conversion | +59 | $4.63 | $273 | 59 |
| 2018-03-26 | Payne Fletcher Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −59 | 74,941 | ||
| 2018-01-12 | Payne Fletcher Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2017-07-11 | Payne Fletcher Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2015-12-17 | Payne Fletcher Chief Financial Officer | Purchase | +10,000 | $2.00 | $20K | 25,032 |
| 2015-10-22 | Payne Fletcher Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +28,572 | 28,572 |
Page 1 of 1 · 12 trades